ADDS Pharmaceuticals, privately funded by Encinal Pharmaceutical Investment, LLC, is a biopharmaceutical company specialized in the development of optimized medicines using its diversified delivery technologies for unmet therapeutical needs. ADDS Pharmaceuticals is headquartered in Silicon Valley, California, USA, with subsidiaries in Nanjin, China. The Company’s most advanced technologies include the fast onset orally dispersible tablets (Fonset), Osmotic capsule with various release profiles including constant, ascending, spatial and temporal release (OsmoCap-CAST), and controlled release of bioavailability-enhancing liquid formulations (L-OROS). Currently, ADDS is actively developing multiple products through its joint venture and collaboration with CROs, as well as seeking new partnerships to further diversify our product portfolio.